Mohamad Mohty

Research interests

Publications

• Prophylaxis and management of graft-versus-host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation

  The Lancet Haematology · 2024 · https://doi.org/10.1016/s2352-3026(23)00342-3

• Elranatamab in relapsed or refractory multiple myeloma: phase 2 MagnetisMM-3 trial results

  Nature Medicine · 2023 · https://doi.org/10.1038/s41591-023-02528-9

• A real-world comparison of tisagenlecleucel and axicabtagene ciloleucel CAR T cells in relapsed or refractory diffuse large B cell lymphoma

  Nature Medicine · 2022 · https://doi.org/10.1038/s41591-022-01969-y

• Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022

  Bone Marrow Transplantation · 2022 · https://doi.org/10.1038/s41409-022-01691-w

• Isatuximab, carfilzomib, and dexamethasone in relapsed multiple myeloma (IKEMA): a multicentre, open-label, randomised phase 3 trial

  The Lancet · 2021 · https://doi.org/10.1016/s0140-6736(21)00592-4

• Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years

  Bone Marrow Transplantation · 2021 · https://doi.org/10.1038/s41409-021-01227-8

• Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years

  Bone Marrow Transplantation · 2021 · https://doi.org/10.1038/s41409-021-01227-8

• Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA)

  Annals of Oncology · 2021 · https://doi.org/10.1016/j.annonc.2021.12.003

• Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation

  The Lancet Haematology · 2020 · https://doi.org/10.1016/s2352-3026(19)30256-x

• Management of patients with acute leukemia during the COVID-19 outbreak: practical guidelines from the acute leukemia working party of the European Society for Blood and Marrow Transplantation

  Bone Marrow Transplantation · 2020 · https://doi.org/10.1038/s41409-020-0970-x

• Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease

  New England Journal of Medicine · 2020 · https://doi.org/10.1056/nejmoa1917635

• Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients

  Bone Marrow Transplantation · 2020 · https://doi.org/10.1038/s41409-020-0803-y

• Indications for haematopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2019

  Bone Marrow Transplantation · 2019 · https://doi.org/10.1038/s41409-019-0516-2

• Minimal residual disease negativity using deep sequencing is a major prognostic factor in multiple myeloma

  Blood · 2018 · https://doi.org/10.1182/blood-2018-06-858613

• Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report

  Bone Marrow Transplantation · 2017 · https://doi.org/10.1038/bmt.2017.34

• Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually

  Bone Marrow Transplantation · 2016 · https://doi.org/10.1038/bmt.2016.20

• Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation

  Bone Marrow Transplantation · 2016 · https://doi.org/10.1038/bmt.2016.130

• Relapse of AML after hematopoietic stem cell transplantation: methods of monitoring and preventive strategies. A review from the ALWP of the EBMT

  Bone Marrow Transplantation · 2016 · https://doi.org/10.1038/bmt.2016.167

• Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015

  Bone Marrow Transplantation · 2015 · https://doi.org/10.1038/bmt.2015.6

• One million haemopoietic stem-cell transplants: a retrospective observational study

  The Lancet Haematology · 2015 · https://doi.org/10.1016/s2352-3026(15)00028-9

• Sinusoidal obstruction syndrome/veno-occlusive disease: current situation and perspectives—a position statement from the European Society for Blood and Marrow Transplantation (EBMT)

  Bone Marrow Transplantation · 2015 · https://doi.org/10.1038/bmt.2015.52

• Prophylaxis and treatment of GVHD: EBMT–ELN working group recommendations for a standardized practice

  Bone Marrow Transplantation · 2013 · https://doi.org/10.1038/bmt.2013.107

• Impact of FLT3 Internal Tandem Duplication on the Outcome of Related and Unrelated Hematopoietic Transplantation for Adult Acute Myeloid Leukemia in First Remission: A Retrospective Analysis

  Journal of Clinical Oncology · 2012 · https://doi.org/10.1200/jco.2011.36.9868

• The European LeukemiaNet AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission: an integrated-risk adapted approach

  Nature Reviews Clinical Oncology · 2012 · https://doi.org/10.1038/nrclinonc.2012.150

• Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation

  Blood · 2010 · https://doi.org/10.1182/blood-2010-01-262089

• Bortezomib Plus Dexamethasone Is Superior to Vincristine Plus Doxorubicin Plus Dexamethasone As Induction Treatment Prior to Autologous Stem-Cell Transplantation in Newly Diagnosed Multiple Myeloma: Results of the IFM 2005-01 Phase III Trial

  Journal of Clinical Oncology · 2010 · https://doi.org/10.1200/jco.2009.27.9158

• Paroxysmal nocturnal hemoglobinuria: natural history of disease subcategories

  Blood · 2008 · https://doi.org/10.1182/blood-2008-01-133918

Current projects

No projects listed.